*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Incidence and types of thyroid tumour in chronic lymphocytic thyroiditis

Author: HUSSAIN TAHER ALBAAJ, AWS RASSUL HUSSAIN AL-SALIH
Abstract: Background: Chronic lymphocytic thyroiditis (CLT) is the most common inflammatory disorder that affects the thyroid gland. It presents either as goitrous (Hashimoto thyroiditis) or atrophic thyroiditis (AT) and the only difference between them is the presence of goiter that detects by clinical examination. The diagnosis is confirmed by the hormonal profile of high TSH with normal or low T3, T4, high autoantibodies, or by FNCA preoperatively. Objectives: The current retrospective study aims to determine the malignant changes in CLT, especially the PTC by analysis of 900 thyroidectomy operations that were undertaken in Diwaniyai hospital from 2014 - 2019. Results: The study revealed 81 cases with HT, all of them were presented to the surgeons because of an un-diagnostic goiter that did not investigate by autoantibodies or by FNCA, and all cases are diagnosed postoperatively by histopathology. 21 patients of them (25%) show malignant changes. PTC has seen in 16 cases (20%) of HT, while 4 cases with lymphoma and only one case with follicular carcinoma. The study also includes an analysis of 156 cases with differentiated thyroid carcinoma (DTC), 142 of them are PTC. In the analysis of histopathology of 156 cases with DTC, HT is seen in 17 cases while no case shows the histopathology of atrophic thyroiditis. This is a big difference between two extremes (AT and HT) of the same disease (CLT). The already high incidence of PTC in HT is further increased when adjusted with age, to be one-third of patient with HT in early adult life (20-40 years) because most of PTC in HT occurs in early adult life. The PTC in HT has its own clinical –pathology feature in comparison with PTC in non HT which are its high incidence in female, earlier age. Smaller size and multiplicity are more frequent. 5 patients of 8 male patients with HT are complicated by malignancy, 3 of them are with lymphoma. Conclusion: all cases of HT must be followed carefully for malignant changes, especially in young adult life and in males.
Keyword: Thyroid tumor; chronic lymphocytic thyroiditis; follicular carcinoma
DOI: https://doi.org/10.31838/ijpr/2021.13.01.584
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free